nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—Doxorubicin—liver cancer	0.614	0.853	CbGbCtD
L-Carnitine—XDH—Doxorubicin—liver cancer	0.106	0.147	CbGbCtD
L-Carnitine—MPO—superior mesenteric artery—liver cancer	0.0386	0.631	CbGeAlD
L-Carnitine—CES1—gall bladder—liver cancer	0.00362	0.0592	CbGeAlD
L-Carnitine—SLC25A29—liver—liver cancer	0.003	0.0491	CbGeAlD
L-Carnitine—CROT—liver—liver cancer	0.00276	0.045	CbGeAlD
L-Carnitine—SLC25A20—liver—liver cancer	0.0024	0.0392	CbGeAlD
L-Carnitine—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.00239	0.0469	CcSEcCtD
L-Carnitine—CRAT—liver—liver cancer	0.00233	0.038	CbGeAlD
L-Carnitine—CPT1A—liver—liver cancer	0.00189	0.0308	CbGeAlD
L-Carnitine—CPT2—liver—liver cancer	0.00179	0.0292	CbGeAlD
L-Carnitine—XDH—liver—liver cancer	0.00139	0.0228	CbGeAlD
L-Carnitine—CES1—liver—liver cancer	0.00106	0.0174	CbGeAlD
L-Carnitine—SLCO1B1—liver—liver cancer	0.000913	0.0149	CbGeAlD
L-Carnitine—Gastritis—Sorafenib—liver cancer	0.000902	0.0177	CcSEcCtD
L-Carnitine—MPO—liver—liver cancer	0.000887	0.0145	CbGeAlD
L-Carnitine—Myasthenia—Epirubicin—liver cancer	0.000826	0.0162	CcSEcCtD
L-Carnitine—Weight decreased—Sorafenib—liver cancer	0.000797	0.0157	CcSEcCtD
L-Carnitine—Renal failure—Sorafenib—liver cancer	0.000772	0.0152	CcSEcCtD
L-Carnitine—Myasthenia—Doxorubicin—liver cancer	0.000764	0.015	CcSEcCtD
L-Carnitine—Hypercalcaemia—Epirubicin—liver cancer	0.000747	0.0147	CcSEcCtD
L-Carnitine—Haemoglobin—Sorafenib—liver cancer	0.000709	0.0139	CcSEcCtD
L-Carnitine—Haemorrhage—Sorafenib—liver cancer	0.000705	0.0138	CcSEcCtD
L-Carnitine—Hypercalcaemia—Doxorubicin—liver cancer	0.000691	0.0136	CcSEcCtD
L-Carnitine—Amblyopia—Epirubicin—liver cancer	0.000672	0.0132	CcSEcCtD
L-Carnitine—Angiopathy—Sorafenib—liver cancer	0.00064	0.0126	CcSEcCtD
L-Carnitine—Arrhythmia—Sorafenib—liver cancer	0.00063	0.0124	CcSEcCtD
L-Carnitine—Amblyopia—Doxorubicin—liver cancer	0.000622	0.0122	CcSEcCtD
L-Carnitine—Dysgeusia—Sorafenib—liver cancer	0.000601	0.0118	CcSEcCtD
L-Carnitine—Cardiovascular disorder—Epirubicin—liver cancer	0.000591	0.0116	CcSEcCtD
L-Carnitine—Muscle spasms—Sorafenib—liver cancer	0.00059	0.0116	CcSEcCtD
L-Carnitine—Anaemia—Sorafenib—liver cancer	0.000568	0.0111	CcSEcCtD
L-Carnitine—Cardiovascular disorder—Doxorubicin—liver cancer	0.000547	0.0107	CcSEcCtD
L-Carnitine—SLC22A5—liver—liver cancer	0.000536	0.00876	CbGeAlD
L-Carnitine—Cough—Sorafenib—liver cancer	0.000536	0.0105	CcSEcCtD
L-Carnitine—Hypertension—Sorafenib—liver cancer	0.00053	0.0104	CcSEcCtD
L-Carnitine—Myalgia—Sorafenib—liver cancer	0.000523	0.0103	CcSEcCtD
L-Carnitine—Injection site reaction—Epirubicin—liver cancer	0.000516	0.0101	CcSEcCtD
L-Carnitine—Hyperkalaemia—Epirubicin—liver cancer	0.00051	0.01	CcSEcCtD
L-Carnitine—Melaena—Epirubicin—liver cancer	0.000507	0.00996	CcSEcCtD
L-Carnitine—Infection—Sorafenib—liver cancer	0.000498	0.00978	CcSEcCtD
L-Carnitine—Anorexia—Sorafenib—liver cancer	0.000478	0.00938	CcSEcCtD
L-Carnitine—Injection site reaction—Doxorubicin—liver cancer	0.000478	0.00938	CcSEcCtD
L-Carnitine—Cramps of lower extremities—Epirubicin—liver cancer	0.000477	0.00936	CcSEcCtD
L-Carnitine—Hyperkalaemia—Doxorubicin—liver cancer	0.000472	0.00927	CcSEcCtD
L-Carnitine—Melaena—Doxorubicin—liver cancer	0.000469	0.00921	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000457	0.00896	CcSEcCtD
L-Carnitine—Hypertonia—Epirubicin—liver cancer	0.000455	0.00893	CcSEcCtD
L-Carnitine—Dyspnoea—Sorafenib—liver cancer	0.000447	0.00877	CcSEcCtD
L-Carnitine—Cramps of lower extremities—Doxorubicin—liver cancer	0.000441	0.00866	CcSEcCtD
L-Carnitine—Dyspepsia—Sorafenib—liver cancer	0.000441	0.00866	CcSEcCtD
L-Carnitine—Decreased appetite—Sorafenib—liver cancer	0.000436	0.00855	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000433	0.00849	CcSEcCtD
L-Carnitine—Pain—Sorafenib—liver cancer	0.000429	0.00841	CcSEcCtD
L-Carnitine—Constipation—Sorafenib—liver cancer	0.000429	0.00841	CcSEcCtD
L-Carnitine—Hypertonia—Doxorubicin—liver cancer	0.000421	0.00827	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Sorafenib—liver cancer	0.00041	0.00805	CcSEcCtD
L-Carnitine—Abdominal pain—Sorafenib—liver cancer	0.000396	0.00778	CcSEcCtD
L-Carnitine—Body temperature increased—Sorafenib—liver cancer	0.000396	0.00778	CcSEcCtD
L-Carnitine—Hypersensitivity—Sorafenib—liver cancer	0.000369	0.00725	CcSEcCtD
L-Carnitine—Asthenia—Sorafenib—liver cancer	0.00036	0.00706	CcSEcCtD
L-Carnitine—Pruritus—Sorafenib—liver cancer	0.000355	0.00696	CcSEcCtD
L-Carnitine—Diarrhoea—Sorafenib—liver cancer	0.000343	0.00673	CcSEcCtD
L-Carnitine—Gastritis—Epirubicin—liver cancer	0.000334	0.00655	CcSEcCtD
L-Carnitine—Muscular weakness—Epirubicin—liver cancer	0.000332	0.00653	CcSEcCtD
L-Carnitine—Dizziness—Sorafenib—liver cancer	0.000331	0.00651	CcSEcCtD
L-Carnitine—Influenza—Epirubicin—liver cancer	0.000326	0.00639	CcSEcCtD
L-Carnitine—Vomiting—Sorafenib—liver cancer	0.000319	0.00626	CcSEcCtD
L-Carnitine—Rash—Sorafenib—liver cancer	0.000316	0.0062	CcSEcCtD
L-Carnitine—Dermatitis—Sorafenib—liver cancer	0.000316	0.0062	CcSEcCtD
L-Carnitine—Headache—Sorafenib—liver cancer	0.000314	0.00616	CcSEcCtD
L-Carnitine—Bronchitis—Epirubicin—liver cancer	0.000313	0.00615	CcSEcCtD
L-Carnitine—Gastritis—Doxorubicin—liver cancer	0.000309	0.00606	CcSEcCtD
L-Carnitine—Muscular weakness—Doxorubicin—liver cancer	0.000308	0.00604	CcSEcCtD
L-Carnitine—Influenza—Doxorubicin—liver cancer	0.000301	0.00592	CcSEcCtD
L-Carnitine—Nausea—Sorafenib—liver cancer	0.000298	0.00584	CcSEcCtD
L-Carnitine—Weight increased—Epirubicin—liver cancer	0.000296	0.00582	CcSEcCtD
L-Carnitine—Weight decreased—Epirubicin—liver cancer	0.000295	0.00579	CcSEcCtD
L-Carnitine—Bronchitis—Doxorubicin—liver cancer	0.00029	0.00569	CcSEcCtD
L-Carnitine—Renal failure—Epirubicin—liver cancer	0.000285	0.0056	CcSEcCtD
L-Carnitine—Urinary tract infection—Epirubicin—liver cancer	0.000282	0.00554	CcSEcCtD
L-Carnitine—Weight increased—Doxorubicin—liver cancer	0.000274	0.00538	CcSEcCtD
L-Carnitine—Weight decreased—Doxorubicin—liver cancer	0.000273	0.00535	CcSEcCtD
L-Carnitine—Sinusitis—Epirubicin—liver cancer	0.000272	0.00535	CcSEcCtD
L-Carnitine—Renal failure—Doxorubicin—liver cancer	0.000264	0.00519	CcSEcCtD
L-Carnitine—Haemoglobin—Epirubicin—liver cancer	0.000262	0.00514	CcSEcCtD
L-Carnitine—Rhinitis—Epirubicin—liver cancer	0.000261	0.00513	CcSEcCtD
L-Carnitine—Urinary tract infection—Doxorubicin—liver cancer	0.000261	0.00513	CcSEcCtD
L-Carnitine—Haemorrhage—Epirubicin—liver cancer	0.000261	0.00512	CcSEcCtD
L-Carnitine—Pharyngitis—Epirubicin—liver cancer	0.000259	0.00508	CcSEcCtD
L-Carnitine—Oedema peripheral—Epirubicin—liver cancer	0.000257	0.00504	CcSEcCtD
L-Carnitine—Sinusitis—Doxorubicin—liver cancer	0.000252	0.00495	CcSEcCtD
L-Carnitine—Eye disorder—Epirubicin—liver cancer	0.000244	0.00478	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—liver cancer	0.000242	0.00476	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—liver cancer	0.000242	0.00475	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—liver cancer	0.000241	0.00474	CcSEcCtD
L-Carnitine—Pharyngitis—Doxorubicin—liver cancer	0.000239	0.0047	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—liver cancer	0.000238	0.00467	CcSEcCtD
L-Carnitine—Angiopathy—Epirubicin—liver cancer	0.000237	0.00464	CcSEcCtD
L-Carnitine—Arrhythmia—Epirubicin—liver cancer	0.000233	0.00457	CcSEcCtD
L-Carnitine—Eye disorder—Doxorubicin—liver cancer	0.000225	0.00443	CcSEcCtD
L-Carnitine—Dysgeusia—Epirubicin—liver cancer	0.000222	0.00436	CcSEcCtD
L-Carnitine—Back pain—Epirubicin—liver cancer	0.00022	0.00431	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—liver cancer	0.000219	0.0043	CcSEcCtD
L-Carnitine—Muscle spasms—Epirubicin—liver cancer	0.000218	0.00428	CcSEcCtD
L-Carnitine—Arrhythmia—Doxorubicin—liver cancer	0.000216	0.00423	CcSEcCtD
L-Carnitine—Anaemia—Epirubicin—liver cancer	0.00021	0.00412	CcSEcCtD
L-Carnitine—Dysgeusia—Doxorubicin—liver cancer	0.000206	0.00404	CcSEcCtD
L-Carnitine—Vertigo—Epirubicin—liver cancer	0.000204	0.004	CcSEcCtD
L-Carnitine—Back pain—Doxorubicin—liver cancer	0.000203	0.00399	CcSEcCtD
L-Carnitine—Muscle spasms—Doxorubicin—liver cancer	0.000202	0.00396	CcSEcCtD
L-Carnitine—Palpitations—Epirubicin—liver cancer	0.000201	0.00394	CcSEcCtD
L-Carnitine—Cough—Epirubicin—liver cancer	0.000198	0.00389	CcSEcCtD
L-Carnitine—Convulsion—Epirubicin—liver cancer	0.000197	0.00386	CcSEcCtD
L-Carnitine—Hypertension—Epirubicin—liver cancer	0.000196	0.00385	CcSEcCtD
L-Carnitine—Anaemia—Doxorubicin—liver cancer	0.000194	0.00381	CcSEcCtD
L-Carnitine—Myalgia—Epirubicin—liver cancer	0.000193	0.00379	CcSEcCtD
L-Carnitine—Chest pain—Epirubicin—liver cancer	0.000193	0.00379	CcSEcCtD
L-Carnitine—Anxiety—Epirubicin—liver cancer	0.000193	0.00378	CcSEcCtD
L-Carnitine—Vertigo—Doxorubicin—liver cancer	0.000189	0.0037	CcSEcCtD
L-Carnitine—Palpitations—Doxorubicin—liver cancer	0.000186	0.00364	CcSEcCtD
L-Carnitine—Infection—Epirubicin—liver cancer	0.000184	0.00361	CcSEcCtD
L-Carnitine—Cough—Doxorubicin—liver cancer	0.000183	0.0036	CcSEcCtD
L-Carnitine—Convulsion—Doxorubicin—liver cancer	0.000182	0.00357	CcSEcCtD
L-Carnitine—Hypertension—Doxorubicin—liver cancer	0.000181	0.00356	CcSEcCtD
L-Carnitine—Tachycardia—Epirubicin—liver cancer	0.000181	0.00355	CcSEcCtD
L-Carnitine—Chest pain—Doxorubicin—liver cancer	0.000179	0.00351	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—liver cancer	0.000179	0.00351	CcSEcCtD
L-Carnitine—Anxiety—Doxorubicin—liver cancer	0.000178	0.0035	CcSEcCtD
L-Carnitine—Anorexia—Epirubicin—liver cancer	0.000177	0.00347	CcSEcCtD
L-Carnitine—Hypotension—Epirubicin—liver cancer	0.000173	0.0034	CcSEcCtD
L-Carnitine—Infection—Doxorubicin—liver cancer	0.00017	0.00334	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000169	0.00331	CcSEcCtD
L-Carnitine—Insomnia—Epirubicin—liver cancer	0.000168	0.00329	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—liver cancer	0.000167	0.00328	CcSEcCtD
L-Carnitine—Paraesthesia—Epirubicin—liver cancer	0.000166	0.00327	CcSEcCtD
L-Carnitine—Dyspnoea—Epirubicin—liver cancer	0.000165	0.00324	CcSEcCtD
L-Carnitine—Anorexia—Doxorubicin—liver cancer	0.000163	0.00321	CcSEcCtD
L-Carnitine—Dyspepsia—Epirubicin—liver cancer	0.000163	0.0032	CcSEcCtD
L-Carnitine—Decreased appetite—Epirubicin—liver cancer	0.000161	0.00316	CcSEcCtD
L-Carnitine—Hypotension—Doxorubicin—liver cancer	0.00016	0.00314	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00016	0.00314	CcSEcCtD
L-Carnitine—Pain—Epirubicin—liver cancer	0.000158	0.00311	CcSEcCtD
L-Carnitine—Constipation—Epirubicin—liver cancer	0.000158	0.00311	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000156	0.00307	CcSEcCtD
L-Carnitine—Insomnia—Doxorubicin—liver cancer	0.000155	0.00304	CcSEcCtD
L-Carnitine—Paraesthesia—Doxorubicin—liver cancer	0.000154	0.00302	CcSEcCtD
L-Carnitine—Dyspnoea—Doxorubicin—liver cancer	0.000153	0.003	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Epirubicin—liver cancer	0.000151	0.00297	CcSEcCtD
L-Carnitine—Dyspepsia—Doxorubicin—liver cancer	0.000151	0.00296	CcSEcCtD
L-Carnitine—Decreased appetite—Doxorubicin—liver cancer	0.000149	0.00292	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000148	0.0029	CcSEcCtD
L-Carnitine—Constipation—Doxorubicin—liver cancer	0.000147	0.00288	CcSEcCtD
L-Carnitine—Pain—Doxorubicin—liver cancer	0.000147	0.00288	CcSEcCtD
L-Carnitine—Abdominal pain—Epirubicin—liver cancer	0.000146	0.00287	CcSEcCtD
L-Carnitine—Body temperature increased—Epirubicin—liver cancer	0.000146	0.00287	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00014	0.00275	CcSEcCtD
L-Carnitine—Hypersensitivity—Epirubicin—liver cancer	0.000136	0.00268	CcSEcCtD
L-Carnitine—Abdominal pain—Doxorubicin—liver cancer	0.000135	0.00266	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—liver cancer	0.000135	0.00266	CcSEcCtD
L-Carnitine—Asthenia—Epirubicin—liver cancer	0.000133	0.00261	CcSEcCtD
L-Carnitine—Pruritus—Epirubicin—liver cancer	0.000131	0.00257	CcSEcCtD
L-Carnitine—Diarrhoea—Epirubicin—liver cancer	0.000127	0.00249	CcSEcCtD
L-Carnitine—Hypersensitivity—Doxorubicin—liver cancer	0.000126	0.00248	CcSEcCtD
L-Carnitine—Asthenia—Doxorubicin—liver cancer	0.000123	0.00241	CcSEcCtD
L-Carnitine—Dizziness—Epirubicin—liver cancer	0.000122	0.0024	CcSEcCtD
L-Carnitine—Pruritus—Doxorubicin—liver cancer	0.000121	0.00238	CcSEcCtD
L-Carnitine—Vomiting—Epirubicin—liver cancer	0.000118	0.00231	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—liver cancer	0.000117	0.0023	CcSEcCtD
L-Carnitine—Rash—Epirubicin—liver cancer	0.000117	0.00229	CcSEcCtD
L-Carnitine—Dermatitis—Epirubicin—liver cancer	0.000117	0.00229	CcSEcCtD
L-Carnitine—Headache—Epirubicin—liver cancer	0.000116	0.00228	CcSEcCtD
L-Carnitine—Dizziness—Doxorubicin—liver cancer	0.000113	0.00222	CcSEcCtD
L-Carnitine—Nausea—Epirubicin—liver cancer	0.00011	0.00216	CcSEcCtD
L-Carnitine—Vomiting—Doxorubicin—liver cancer	0.000109	0.00214	CcSEcCtD
L-Carnitine—Rash—Doxorubicin—liver cancer	0.000108	0.00212	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—liver cancer	0.000108	0.00212	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—liver cancer	0.000107	0.00211	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000104	0.000619	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—HMOX1—liver cancer	0.000103	0.000612	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000103	0.000608	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000103	0.000608	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALDOB—liver cancer	0.000102	0.000606	CbGpPWpGaD
L-Carnitine—Nausea—Doxorubicin—liver cancer	0.000102	0.002	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000101	0.000601	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000101	0.000601	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYCS—liver cancer	0.000101	0.000599	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYCS—liver cancer	0.000101	0.000599	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—UGDH—liver cancer	0.0001	0.000595	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.0001	0.000595	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—GGT1—liver cancer	9.93e-05	0.000589	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GOT1—liver cancer	9.9e-05	0.000587	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GGT1—liver cancer	9.9e-05	0.000587	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GOT1—liver cancer	9.9e-05	0.000587	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GGT1—liver cancer	9.9e-05	0.000587	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CRABP1—liver cancer	9.76e-05	0.000579	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSTM1—liver cancer	9.61e-05	0.00057	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—NR1H4—liver cancer	9.59e-05	0.000569	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—JUN—liver cancer	9.58e-05	0.000568	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC40A1—liver cancer	9.56e-05	0.000567	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—EPT1—liver cancer	9.43e-05	0.000559	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—HRAS—liver cancer	9.21e-05	0.000546	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—TNF—liver cancer	9.2e-05	0.000546	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CPT1B—liver cancer	9.17e-05	0.000544	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GLUL—liver cancer	9.17e-05	0.000544	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ANXA2—liver cancer	9.17e-05	0.000544	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ATP7B—liver cancer	9.17e-05	0.000544	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ALB—liver cancer	9.17e-05	0.000544	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CYP1A1—liver cancer	9.11e-05	0.000541	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—MAPK8—liver cancer	9.07e-05	0.000538	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TAT—liver cancer	8.94e-05	0.00053	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTP1—liver cancer	8.9e-05	0.000528	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTP1—liver cancer	8.9e-05	0.000528	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NR1H4—liver cancer	8.84e-05	0.000525	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TNF—liver cancer	8.79e-05	0.000521	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.78e-05	0.000521	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—HMOX1—liver cancer	8.77e-05	0.00052	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—HMOX1—liver cancer	8.77e-05	0.00052	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTA3—liver cancer	8.69e-05	0.000516	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—NR1H4—liver cancer	8.67e-05	0.000514	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—HPGDS—liver cancer	8.53e-05	0.000506	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—MTHFR—liver cancer	8.5e-05	0.000504	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—IL6—liver cancer	8.5e-05	0.000504	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.48e-05	0.000503	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PPARA—liver cancer	8.34e-05	0.000494	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—RAF1—liver cancer	8.29e-05	0.000492	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTM1—liver cancer	8.17e-05	0.000485	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTM1—liver cancer	8.17e-05	0.000485	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—TGFB1—liver cancer	8.09e-05	0.00048	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTA4—liver cancer	7.95e-05	0.000472	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	7.77e-05	0.000461	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTA2—liver cancer	7.75e-05	0.00046	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP1A1—liver cancer	7.75e-05	0.00046	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP1A1—liver cancer	7.75e-05	0.00046	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.72e-05	0.000458	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.62e-05	0.000452	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC11A2—liver cancer	7.61e-05	0.000451	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PSMA4—liver cancer	7.6e-05	0.000451	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PSMD10—liver cancer	7.6e-05	0.000451	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.49e-05	0.000444	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTA1—liver cancer	7.48e-05	0.000443	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—IL6—liver cancer	7.43e-05	0.00044	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NAT2—liver cancer	7.39e-05	0.000438	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GOT2—liver cancer	7.39e-05	0.000438	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC40A1—liver cancer	7.26e-05	0.000431	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—MTHFR—liver cancer	7.22e-05	0.000428	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—MTHFR—liver cancer	7.22e-05	0.000428	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	7.18e-05	0.000426	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CG—liver cancer	7.14e-05	0.000423	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.11e-05	0.000422	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL6—liver cancer	7.09e-05	0.000421	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALDOB—liver cancer	7.09e-05	0.00042	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PPARA—liver cancer	7.09e-05	0.00042	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PPARA—liver cancer	7.09e-05	0.00042	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ATP7B—liver cancer	6.96e-05	0.000413	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ANXA2—liver cancer	6.96e-05	0.000413	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP2E1—liver cancer	6.95e-05	0.000412	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	6.92e-05	0.000411	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PPARG—liver cancer	6.89e-05	0.000409	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CRABP1—liver cancer	6.76e-05	0.000401	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.73e-05	0.000399	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—ALB—liver cancer	6.68e-05	0.000396	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—NR1H4—liver cancer	6.58e-05	0.00039	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYCS—liver cancer	6.5e-05	0.000386	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—CYCS—liver cancer	6.5e-05	0.000386	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GOT1—liver cancer	6.38e-05	0.000378	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GGT1—liver cancer	6.38e-05	0.000378	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.37e-05	0.000378	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.37e-05	0.000378	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—liver cancer	6.32e-05	0.000375	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CD—liver cancer	6.28e-05	0.000372	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—ALB—liver cancer	6.2e-05	0.000367	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.09e-05	0.000361	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CPT1B—liver cancer	6.08e-05	0.00036	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GLUL—liver cancer	6.08e-05	0.00036	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CG—liver cancer	6.07e-05	0.00036	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CG—liver cancer	6.07e-05	0.00036	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—HPGDS—liver cancer	5.91e-05	0.000351	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.88e-05	0.000348	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PPARG—liver cancer	5.86e-05	0.000347	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NR1H4—liver cancer	5.86e-05	0.000347	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PPARG—liver cancer	5.86e-05	0.000347	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—IL6—liver cancer	5.79e-05	0.000343	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTA3—liver cancer	5.76e-05	0.000342	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTP1—liver cancer	5.73e-05	0.00034	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—HMOX1—liver cancer	5.65e-05	0.000335	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—HMOX1—liver cancer	5.65e-05	0.000335	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CB—liver cancer	5.47e-05	0.000324	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.35e-05	0.000317	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CD—liver cancer	5.34e-05	0.000316	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CD—liver cancer	5.34e-05	0.000316	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.29e-05	0.000314	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.28e-05	0.000313	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—UGDH—liver cancer	5.28e-05	0.000313	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ALB—liver cancer	5.27e-05	0.000312	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PSMD10—liver cancer	5.27e-05	0.000312	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ALB—liver cancer	5.27e-05	0.000312	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PSMA4—liver cancer	5.27e-05	0.000312	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTA4—liver cancer	5.27e-05	0.000312	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTM1—liver cancer	5.27e-05	0.000312	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTA2—liver cancer	5.13e-05	0.000304	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GOT2—liver cancer	5.12e-05	0.000304	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—ALB—liver cancer	5.02e-05	0.000298	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP1A1—liver cancer	4.99e-05	0.000296	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—EPT1—liver cancer	4.96e-05	0.000294	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTA1—liver cancer	4.95e-05	0.000294	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NAT2—liver cancer	4.9e-05	0.00029	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—CYCS—liver cancer	4.89e-05	0.00029	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP2E1—liver cancer	4.82e-05	0.000286	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TAT—liver cancer	4.7e-05	0.000279	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALDOB—liver cancer	4.7e-05	0.000278	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.66e-05	0.000277	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—MTHFR—liver cancer	4.66e-05	0.000276	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CB—liver cancer	4.65e-05	0.000276	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CB—liver cancer	4.65e-05	0.000276	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.63e-05	0.000274	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPARA—liver cancer	4.57e-05	0.000271	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—PPARA—liver cancer	4.57e-05	0.000271	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	4.54e-05	0.000269	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYCS—liver cancer	4.51e-05	0.000267	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CRABP1—liver cancer	4.48e-05	0.000266	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GGT1—liver cancer	4.42e-05	0.000262	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GOT1—liver cancer	4.42e-05	0.000262	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	4.42e-05	0.000262	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—HMOX1—liver cancer	4.25e-05	0.000252	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.1e-05	0.000243	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTP1—liver cancer	3.97e-05	0.000236	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—HMOX1—liver cancer	3.92e-05	0.000232	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HPGDS—liver cancer	3.92e-05	0.000232	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CG—liver cancer	3.91e-05	0.000232	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	3.84e-05	0.000228	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPARG—liver cancer	3.78e-05	0.000224	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTM1—liver cancer	3.65e-05	0.000217	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PSMA4—liver cancer	3.49e-05	0.000207	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PSMD10—liver cancer	3.49e-05	0.000207	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.46e-05	0.000205	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1A1—liver cancer	3.46e-05	0.000205	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—ALB—liver cancer	3.45e-05	0.000204	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CD—liver cancer	3.44e-05	0.000204	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—PPARA—liver cancer	3.43e-05	0.000204	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GOT2—liver cancer	3.39e-05	0.000201	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALB—liver cancer	3.39e-05	0.000201	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ALB—liver cancer	3.39e-05	0.000201	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—CYCS—liver cancer	3.36e-05	0.000199	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—liver cancer	3.33e-05	0.000198	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—MTHFR—liver cancer	3.23e-05	0.000191	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GLUL—liver cancer	3.2e-05	0.00019	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CPT1B—liver cancer	3.2e-05	0.00019	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2E1—liver cancer	3.19e-05	0.000189	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPARA—liver cancer	3.17e-05	0.000188	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	3.1e-05	0.000184	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NR1H4—liver cancer	3.08e-05	0.000183	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—RAF1—liver cancer	3.07e-05	0.000182	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA3—liver cancer	3.03e-05	0.00018	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CB—liver cancer	3e-05	0.000178	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYCS—liver cancer	2.99e-05	0.000177	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GOT1—liver cancer	2.93e-05	0.000174	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GGT1—liver cancer	2.93e-05	0.000174	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—liver cancer	2.92e-05	0.000173	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.84e-05	0.000169	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—liver cancer	2.84e-05	0.000168	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—liver cancer	2.84e-05	0.000168	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA4—liver cancer	2.77e-05	0.000164	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—liver cancer	2.72e-05	0.000162	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CG—liver cancer	2.71e-05	0.000161	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.71e-05	0.000161	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA2—liver cancer	2.7e-05	0.00016	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTP1—liver cancer	2.63e-05	0.000156	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPARG—liver cancer	2.62e-05	0.000155	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA1—liver cancer	2.61e-05	0.000155	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HMOX1—liver cancer	2.6e-05	0.000154	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NAT2—liver cancer	2.58e-05	0.000153	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ALB—liver cancer	2.55e-05	0.000151	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.48e-05	0.000147	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALDOB—liver cancer	2.47e-05	0.000147	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTM1—liver cancer	2.42e-05	0.000143	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CD—liver cancer	2.38e-05	0.000141	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CRABP1—liver cancer	2.36e-05	0.00014	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—PPARA—liver cancer	2.36e-05	0.00014	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALB—liver cancer	2.35e-05	0.00014	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—liver cancer	2.32e-05	0.000137	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—liver cancer	2.32e-05	0.000137	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	2.31e-05	0.000137	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—RAF1—liver cancer	2.31e-05	0.000137	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1A1—liver cancer	2.29e-05	0.000136	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MTHFR—liver cancer	2.14e-05	0.000127	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.12e-05	0.000126	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPARA—liver cancer	2.1e-05	0.000124	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	2.09e-05	0.000124	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CB—liver cancer	2.08e-05	0.000123	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HPGDS—liver cancer	2.06e-05	0.000122	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.05e-05	0.000121	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.87e-05	0.000111	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.84e-05	0.000109	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PSMA4—liver cancer	1.84e-05	0.000109	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PSMD10—liver cancer	1.84e-05	0.000109	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—liver cancer	1.83e-05	0.000108	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CG—liver cancer	1.8e-05	0.000107	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GOT2—liver cancer	1.79e-05	0.000106	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ALB—liver cancer	1.75e-05	0.000104	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPARG—liver cancer	1.73e-05	0.000103	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2E1—liver cancer	1.68e-05	9.96e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.63e-05	9.65e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	1.58e-05	9.39e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CD—liver cancer	1.58e-05	9.36e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYCS—liver cancer	1.57e-05	9.32e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALB—liver cancer	1.56e-05	9.24e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GOT1—liver cancer	1.54e-05	9.15e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GGT1—liver cancer	1.54e-05	9.15e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—liver cancer	1.49e-05	8.85e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTP1—liver cancer	1.39e-05	8.22e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CB—liver cancer	1.38e-05	8.16e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HMOX1—liver cancer	1.37e-05	8.1e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTM1—liver cancer	1.27e-05	7.55e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—liver cancer	1.27e-05	7.51e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1A1—liver cancer	1.21e-05	7.16e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTHFR—liver cancer	1.13e-05	6.67e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARA—liver cancer	1.1e-05	6.55e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—liver cancer	1.03e-05	6.14e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.91e-06	5.88e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CG—liver cancer	9.45e-06	5.61e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARG—liver cancer	9.12e-06	5.41e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—liver cancer	8.39e-06	4.98e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CD—liver cancer	8.31e-06	4.93e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALB—liver cancer	8.2e-06	4.87e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CB—liver cancer	7.24e-06	4.3e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—liver cancer	6.85e-06	4.06e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—liver cancer	4.42e-06	2.62e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—liver cancer	3.61e-06	2.14e-05	CbGpPWpGaD
